Related Experiment Video

Updated: Jul 16, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Links between innate and cognate tumor immunity

François Ghiringhelli1, Lionel Apetoh, Frank Housseau

  • 1U805 Institut National de la Santé et de la Recherche Médicale, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France.

Current Opinion in Immunology
|February 17, 2007
PubMed

Insights

Cancer immunity involves complex interactions between innate and adaptive immune cells. Novel interferon-producing killer dendritic cells bridge these systems, enhancing anti-tumor responses and T-cell priming for cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Cancer arises from genetic dysregulation and immune evasion.
  • Cellular interactions are key to mounting anti-tumor immune responses.
  • Links between innate and adaptive immunity are crucial for T-cell responses.

Purpose of the Study:

  • To explore the interplay between innate and adaptive immunity in anti-tumor responses.
  • To highlight the role of dendritic cells in T-cell priming within the tumor microenvironment.
  • To investigate novel effector cells and their functions in cancer immunity.

Main Methods:

  • Analysis of cellular interactions in the tumor microenvironment.
  • Investigation of dendritic cell differentiation and maturation pathways.
  • Characterization of novel innate effector cells, including interferon-producing killer dendritic cells.

Main Results:

  • Dendritic cell maturation in the tumor microenvironment is critical for T-cell priming.
  • Innate immune cells can sense transformed cells and modulate dendritic cell activation.
  • Interferon-producing killer dendritic cells recognize, kill transformed cells, and present antigens.
  • Therapy-induced cell death can promote innate-adaptive immune interactions for anti-tumor effects.

Conclusions:

  • The intricate network of innate and adaptive immunity is essential for effective anti-tumor responses.
  • Interferon-producing killer dendritic cells represent a novel therapeutic target for cancer immunotherapy.
  • Understanding these cellular interactions can lead to improved cancer treatment strategies.

More Related Videos

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model07:49

Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

Published on: April 13, 2015

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.